Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura; the “Company”) has confirmed that a report concerning the Company and its group companies was published by Gotham City Research LLC on August 3, 2026. The report reflects the independent views and assertions of its author and was not issued by the Company.
Continue reading: SCC News Release 2-8.4.2026